Key points are not available for this paper at this time.
Portopulmonary hypertension (PoPH), associated with increased mortality, can limit treatment options for liver diseases. Data on the continuum of clinical risk related to cardiopulmonary hemodynamics in PoPH are lacking.
Jose et al. (Wed,) studied this question.